Plantar Fasciitis Can Be Treated

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The approval makes dupilumab available to treat uncontrolled CRSwNP in adolescents aged 12 to 17 years, expanding on the current approved range of 18 years and older.

October 25th 2023

Atrial Fibrillation in the US 3-Fold More Prevalent Than Previously Estimated, New Data Suggest

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Rose McNulty

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Approximately 10.5 million US adults, or 5% of the population, have the atrial fibrillation, according to new prevalence estimates.

August 30th 2023

GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose

The GSK reformulation induced acceptable immune responses for both influenza A and B strains, overcoming a setback earlier in the ability to successfully neutralize the latter.

FDA Approves Dupilumab Label Expansion with Indication for CRSwNP in Adolescents

Your daily dose of the clinical news you may have missed.

Related Content

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The approval makes dupilumab available to treat uncontrolled CRSwNP in adolescents aged 12 to 17 years, expanding on the current approved range of 18 years and older.

October 25th 2023

Atrial Fibrillation in the US 3-Fold More Prevalent Than Previously Estimated, New Data Suggest

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Rose McNulty

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Approximately 10.5 million US adults, or 5% of the population, have the atrial fibrillation, according to new prevalence estimates.

August 30th 2023

GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose

The GSK reformulation induced acceptable immune responses for both influenza A and B strains, overcoming a setback earlier in the ability to successfully neutralize the latter.